| 0 |
DEVICE SIGNAL DETECTION ISSUE |
1 |
0.0769 |
| 1 |
EXTRA-AXIAL HAEMORRHAGE |
1 |
0.0588 |
| 2 |
SCAR INFLAMMATION |
2 |
0.0571 |
| 3 |
ANTACID THERAPY |
4 |
0.0308 |
| 4 |
CONGENITAL HIATUS HERNIA |
6 |
0.0263 |
| 5 |
SLEEP DISORDER THERAPY |
5 |
0.0253 |
| 6 |
GASTROINTESTINAL DILATION PROCEDURE |
1 |
0.0213 |
| 7 |
HAEMORRHAGE NEONATAL |
1 |
0.0192 |
| 8 |
MALIGNANT MELANOMA STAGE 0 |
4 |
0.0191 |
| 9 |
BLOOD CHLORIDE ABNORMAL |
3 |
0.0185 |
| 10 |
CRACKLES LUNG |
1 |
0.0161 |
| 11 |
ANALGESIC THERAPY |
5 |
0.0156 |
| 12 |
DRUG THERAPY |
5 |
0.0147 |
| 13 |
HEREDITARY OPTIC ATROPHY |
1 |
0.0143 |
| 14 |
ANTICOAGULANT THERAPY |
4 |
0.0141 |
| 15 |
PULMONARY ARTERY OCCLUSION |
1 |
0.0104 |
| 16 |
GLOSSOPTOSIS |
2 |
0.0091 |
| 17 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 18 |
INTENTIONAL PRODUCT MISUSE TO CHILD |
1 |
0.0078 |
| 19 |
GASTROINTESTINAL STOMA OUTPUT DECREASED |
1 |
0.0071 |
| 20 |
WRONG PRODUCT STORED |
2 |
0.0070 |
| 21 |
URINARY BLADDER SUSPENSION |
1 |
0.0061 |
| 22 |
PRODUCT COMPOUNDING QUALITY ISSUE |
2 |
0.0055 |
| 23 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
1 |
0.0055 |
| 24 |
MOUTH BREATHING |
2 |
0.0046 |
| 25 |
ACINETOBACTER INFECTION |
5 |
0.0046 |
| 26 |
SEVERE ACUTE RESPIRATORY SYNDROME |
1 |
0.0045 |
| 27 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
4 |
0.0043 |
| 28 |
ANAL INFECTION |
1 |
0.0039 |
| 29 |
BLOOD MAGNESIUM INCREASED |
3 |
0.0033 |
| 30 |
PRODUCT APPEARANCE CONFUSION |
3 |
0.0032 |
| 31 |
PROTEIN DEFICIENCY |
1 |
0.0032 |
| 32 |
BLOOD OSMOLARITY INCREASED |
1 |
0.0030 |
| 33 |
RESPIRATORY GAS EXCHANGE DISORDER |
1 |
0.0027 |
| 34 |
APPENDICOLITH |
1 |
0.0026 |
| 35 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0026 |
| 36 |
GASTROINTESTINAL ANASTOMOTIC LEAK |
1 |
0.0026 |
| 37 |
BRADYCARDIA FOETAL |
2 |
0.0024 |
| 38 |
NECROTISING COLITIS |
3 |
0.0024 |
| 39 |
HYPERPHOSPHATAEMIA |
5 |
0.0023 |
| 40 |
NITRITE URINE PRESENT |
1 |
0.0023 |
| 41 |
INTERCEPTED DRUG ADMINISTRATION ERROR |
1 |
0.0023 |
| 42 |
CATHETER SITE RASH |
1 |
0.0022 |
| 43 |
AIR EMBOLISM |
1 |
0.0021 |
| 44 |
MARKEDLY REDUCED DIETARY INTAKE |
1 |
0.0020 |
| 45 |
HEPATIC ADENOMA |
1 |
0.0019 |
| 46 |
BODY TEMPERATURE ABNORMAL |
3 |
0.0016 |
| 47 |
PLATELET TRANSFUSION |
2 |
0.0016 |
| 48 |
KLEBSIELLA TEST POSITIVE |
1 |
0.0015 |
| 49 |
STOMA SITE DISCHARGE |
4 |
0.0015 |
| 50 |
PLEURITIC PAIN |
4 |
0.0014 |
| 51 |
PROPOFOL INFUSION SYNDROME |
1 |
0.0014 |
| 52 |
RESPIRATORY SYMPTOM |
4 |
0.0014 |
| 53 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
7 |
0.0014 |
| 54 |
LIP EROSION |
1 |
0.0014 |
| 55 |
INTELLECTUAL DISABILITY |
2 |
0.0013 |
| 56 |
PULMONARY ARTERY THROMBOSIS |
1 |
0.0013 |
| 57 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 58 |
HAEMOPERITONEUM |
1 |
0.0012 |
| 59 |
PRODUCT PACKAGING CONFUSION |
3 |
0.0012 |
| 60 |
BREATH SOUNDS ABNORMAL |
6 |
0.0012 |
| 61 |
BOTULISM |
1 |
0.0012 |
| 62 |
OESOPHAGEAL OBSTRUCTION |
1 |
0.0012 |
| 63 |
PUPILLARY REFLEX IMPAIRED |
2 |
0.0011 |
| 64 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 65 |
ANTIBIOTIC THERAPY |
1 |
0.0010 |
| 66 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 67 |
ARRHYTHMIA SUPRAVENTRICULAR |
1 |
0.0009 |
| 68 |
PILOERECTION |
1 |
0.0009 |
| 69 |
TONSILLAR DISORDER |
1 |
0.0009 |
| 70 |
CLOSTRIDIAL INFECTION |
3 |
0.0009 |
| 71 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 72 |
DILATATION ATRIAL |
1 |
0.0009 |
| 73 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 74 |
PUSTULE |
2 |
0.0008 |
| 75 |
SYSTEMIC CANDIDA |
2 |
0.0008 |
| 76 |
BRADYCARDIA NEONATAL |
1 |
0.0008 |
| 77 |
FISTULA DISCHARGE |
1 |
0.0008 |
| 78 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 79 |
FAILURE TO THRIVE |
4 |
0.0008 |
| 80 |
TONIC CLONIC MOVEMENTS |
1 |
0.0008 |
| 81 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 82 |
URINE OUTPUT INCREASED |
2 |
0.0008 |
| 83 |
PACKED RED BLOOD CELL TRANSFUSION |
1 |
0.0008 |
| 84 |
GLYCOSURIA |
1 |
0.0007 |
| 85 |
PRODUCT LABEL CONFUSION |
4 |
0.0007 |
| 86 |
HYPOPHOSPHATAEMIA |
5 |
0.0007 |
| 87 |
INTERCEPTED DRUG DISPENSING ERROR |
1 |
0.0007 |
| 88 |
CALCULUS URINARY |
1 |
0.0006 |
| 89 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 90 |
OSTEOSCLEROSIS |
1 |
0.0006 |
| 91 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 92 |
MYASTHENIA GRAVIS |
5 |
0.0006 |
| 93 |
HYPOGLYCAEMIA NEONATAL |
1 |
0.0006 |
| 94 |
RESUSCITATION |
1 |
0.0006 |
| 95 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 96 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 97 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 98 |
OPPORTUNISTIC INFECTION |
1 |
0.0005 |
| 99 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 100 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 101 |
TROPONIN INCREASED |
4 |
0.0005 |
| 102 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 103 |
TONGUE BITING |
1 |
0.0005 |
| 104 |
ATRIAL TACHYCARDIA |
1 |
0.0005 |
| 105 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 106 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 107 |
SPUTUM INCREASED |
1 |
0.0005 |
| 108 |
BLOOD CALCIUM INCREASED |
4 |
0.0005 |
| 109 |
ACCIDENT AT WORK |
1 |
0.0005 |
| 110 |
WRONG DRUG ADMINISTERED |
4 |
0.0004 |
| 111 |
MALNUTRITION |
5 |
0.0004 |
| 112 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 113 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 114 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 115 |
TRANSPLANT |
1 |
0.0004 |
| 116 |
URINARY HESITATION |
1 |
0.0004 |
| 117 |
HYPERCHOLESTEROLAEMIA |
4 |
0.0004 |
| 118 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 119 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 120 |
BRAIN ABSCESS |
1 |
0.0004 |
| 121 |
FULL BLOOD COUNT ABNORMAL |
4 |
0.0004 |
| 122 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 123 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 124 |
ASPIRATION |
4 |
0.0004 |
| 125 |
EMBOLISM |
3 |
0.0004 |
| 126 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 127 |
BLOOD TEST ABNORMAL |
5 |
0.0004 |
| 128 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 129 |
MICTURITION URGENCY |
4 |
0.0003 |
| 130 |
MYOPATHY |
3 |
0.0003 |
| 131 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 132 |
BACTERIAL INFECTION |
6 |
0.0003 |
| 133 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 134 |
HAEMOGLOBIN ABNORMAL |
2 |
0.0003 |
| 135 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 136 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
| 137 |
BODY TEMPERATURE DECREASED |
3 |
0.0003 |
| 138 |
OTITIS MEDIA |
1 |
0.0003 |
| 139 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 140 |
DRUG TOXICITY |
4 |
0.0003 |
| 141 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 142 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 143 |
GRANULOMA |
1 |
0.0003 |
| 144 |
NEURALGIA |
7 |
0.0003 |
| 145 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 146 |
NEUTROPENIC SEPSIS |
2 |
0.0003 |
| 147 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 148 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 149 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 150 |
BLOOD SODIUM DECREASED |
5 |
0.0003 |
| 151 |
DRUG DISPENSING ERROR |
4 |
0.0003 |
| 152 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 153 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 154 |
ULCER |
4 |
0.0003 |
| 155 |
HYPERPHAGIA |
1 |
0.0003 |
| 156 |
NEPHROLITHIASIS |
11 |
0.0002 |
| 157 |
BLOOD UREA INCREASED |
4 |
0.0002 |
| 158 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 159 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 160 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 161 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 162 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 163 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 164 |
GOUT |
4 |
0.0002 |
| 165 |
IRON DEFICIENCY |
1 |
0.0002 |
| 166 |
URINE ABNORMALITY |
1 |
0.0002 |
| 167 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 168 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 169 |
MENTAL STATUS CHANGES |
6 |
0.0002 |
| 170 |
PULMONARY ARTERIAL HYPERTENSION |
3 |
0.0002 |
| 171 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 172 |
HYPOTONIA |
2 |
0.0002 |
| 173 |
UPPER RESPIRATORY TRACT INFECTION |
9 |
0.0002 |
| 174 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 175 |
LUNG INFECTION |
3 |
0.0002 |
| 176 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 177 |
TENDERNESS |
2 |
0.0002 |
| 178 |
JOINT INJURY |
4 |
0.0002 |
| 179 |
CHEILITIS |
1 |
0.0002 |
| 180 |
HYDROCEPHALUS |
1 |
0.0002 |
| 181 |
TIC |
1 |
0.0002 |
| 182 |
COAGULOPATHY |
3 |
0.0002 |
| 183 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 184 |
ANGIOPATHY |
1 |
0.0002 |
| 185 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 186 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
5 |
0.0002 |
| 187 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 188 |
SHOCK |
4 |
0.0002 |
| 189 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 190 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 191 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 192 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
| 193 |
BACTERAEMIA |
2 |
0.0002 |
| 194 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 195 |
AGRANULOCYTOSIS |
3 |
0.0002 |
| 196 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 197 |
HYPONATRAEMIA |
9 |
0.0002 |
| 198 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 199 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 200 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 201 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 202 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 203 |
SOPOR |
2 |
0.0002 |
| 204 |
APPETITE DISORDER |
1 |
0.0002 |
| 205 |
TERMINAL STATE |
1 |
0.0001 |
| 206 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 207 |
TACHYPNOEA |
2 |
0.0001 |
| 208 |
PNEUMONITIS |
4 |
0.0001 |
| 209 |
ENCEPHALITIS |
1 |
0.0001 |
| 210 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 211 |
DIALYSIS |
2 |
0.0001 |
| 212 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 213 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 214 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
3 |
0.0001 |
| 215 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 216 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
7 |
0.0001 |
| 217 |
KETOACIDOSIS |
1 |
0.0001 |
| 218 |
CORONARY ARTERY DISEASE |
4 |
0.0001 |
| 219 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 220 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 221 |
ALANINE AMINOTRANSFERASE INCREASED |
8 |
0.0001 |
| 222 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 223 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 224 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 225 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 226 |
CYANOSIS |
2 |
0.0001 |
| 227 |
MEDICATION ERROR |
7 |
0.0001 |
| 228 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 229 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 230 |
DECUBITUS ULCER |
1 |
0.0001 |
| 231 |
POLYURIA |
1 |
0.0001 |
| 232 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 233 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 234 |
TRANSIENT ISCHAEMIC ATTACK |
4 |
0.0001 |
| 235 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 236 |
CARDIAC OPERATION |
1 |
0.0001 |
| 237 |
PYELONEPHRITIS |
1 |
0.0001 |
| 238 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 239 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 240 |
LUNG INFILTRATION |
1 |
0.0001 |
| 241 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 242 |
GENERAL PHYSICAL HEALTH DETERIORATION |
13 |
0.0001 |
| 243 |
CARDIOTOXICITY |
1 |
0.0001 |
| 244 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 245 |
HYPERGLYCAEMIA |
4 |
0.0001 |
| 246 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 247 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 248 |
NEPHROPATHY |
1 |
0.0001 |
| 249 |
APPENDICITIS |
1 |
0.0001 |
| 250 |
LACERATION |
1 |
0.0001 |
| 251 |
SPINAL DISORDER |
1 |
0.0001 |
| 252 |
FEBRILE NEUTROPENIA |
7 |
0.0001 |
| 253 |
ATELECTASIS |
1 |
0.0001 |
| 254 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 255 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 256 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 257 |
EYELID PTOSIS |
1 |
0.0001 |
| 258 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 259 |
SLUGGISHNESS |
1 |
0.0001 |
| 260 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 261 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 262 |
EYE DISCHARGE |
1 |
0.0001 |
| 263 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 264 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 265 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 266 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 267 |
LIVER DISORDER |
4 |
0.0001 |
| 268 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 269 |
FUNGAL INFECTION |
3 |
0.0001 |
| 270 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 271 |
SEPSIS |
10 |
0.0001 |
| 272 |
FISTULA |
1 |
0.0001 |
| 273 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 274 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 275 |
LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 276 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 277 |
THROMBOSIS |
7 |
0.0001 |
| 278 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 279 |
HYPOXIA |
3 |
0.0001 |
| 280 |
PULMONARY EMBOLISM |
8 |
0.0001 |
| 281 |
RESPIRATORY FAILURE |
6 |
0.0001 |
| 282 |
LUNG DISORDER |
4 |
0.0001 |
| 283 |
FEELING HOT |
5 |
0.0001 |
| 284 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 285 |
CARDIOMEGALY |
1 |
0.0001 |
| 286 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 287 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 288 |
DYSARTHRIA |
3 |
0.0001 |
| 289 |
ANOREXIA |
1 |
0.0001 |
| 290 |
HIATUS HERNIA |
1 |
0.0001 |
| 291 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 292 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 293 |
DISORIENTATION |
3 |
0.0001 |
| 294 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 295 |
SINUS CONGESTION |
1 |
0.0001 |
| 296 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 297 |
ANAEMIA |
14 |
0.0001 |
| 298 |
MOOD ALTERED |
2 |
0.0001 |
| 299 |
FEELING COLD |
2 |
0.0001 |
| 300 |
HUNGER |
1 |
0.0001 |
| 301 |
MASS |
1 |
0.0001 |
| 302 |
SLEEP DISORDER |
5 |
0.0001 |
| 303 |
PARALYSIS |
1 |
0.0001 |
| 304 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 305 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 306 |
FLUID OVERLOAD |
1 |
0.0001 |
| 307 |
BONE PAIN |
4 |
0.0001 |
| 308 |
ASCITES |
2 |
0.0001 |
| 309 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 310 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 311 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 312 |
PYREXIA |
23 |
0.0001 |
| 313 |
NO ADVERSE EVENT |
12 |
0.0001 |
| 314 |
DIABETES MELLITUS |
5 |
0.0001 |
| 315 |
HYPOKALAEMIA |
3 |
0.0001 |
| 316 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 317 |
OBESITY |
1 |
0.0001 |
| 318 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 319 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 320 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 321 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 322 |
EYE DISORDER |
2 |
0.0001 |
| 323 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 324 |
DEHYDRATION |
8 |
0.0001 |
| 325 |
FACE OEDEMA |
1 |
0.0001 |
| 326 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 327 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 328 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 329 |
NEUROTOXICITY |
1 |
0.0001 |
| 330 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 331 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 332 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 333 |
THIRST |
1 |
0.0001 |
| 334 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 335 |
OEDEMA |
3 |
0.0001 |
| 336 |
INFECTION |
8 |
0.0001 |
| 337 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 338 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 339 |
SWELLING |
5 |
0.0001 |
| 340 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 341 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 342 |
HALLUCINATION |
4 |
0.0001 |
| 343 |
FLATULENCE |
3 |
0.0001 |
| 344 |
PROTEINURIA |
1 |
0.0001 |
| 345 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 346 |
GLAUCOMA |
1 |
0.0001 |
| 347 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 348 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 349 |
SOMNOLENCE |
10 |
0.0000 |
| 350 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 351 |
PNEUMONIA |
16 |
0.0000 |
| 352 |
FEEDING DISORDER |
1 |
0.0000 |
| 353 |
TASTE DISORDER |
1 |
0.0000 |
| 354 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 355 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 356 |
EATING DISORDER |
1 |
0.0000 |
| 357 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 358 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 359 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 360 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 361 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 362 |
CHROMATURIA |
1 |
0.0000 |
| 363 |
SEIZURE |
5 |
0.0000 |
| 364 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 365 |
CONDITION AGGRAVATED |
13 |
0.0000 |
| 366 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 367 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 368 |
PRESYNCOPE |
1 |
0.0000 |
| 369 |
UNDERDOSE |
3 |
0.0000 |
| 370 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 371 |
LIVER INJURY |
1 |
0.0000 |
| 372 |
ABASIA |
1 |
0.0000 |
| 373 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 374 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 375 |
LEUKOPENIA |
2 |
0.0000 |
| 376 |
HYPOPHAGIA |
1 |
0.0000 |
| 377 |
HOSPITALISATION |
6 |
0.0000 |
| 378 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 379 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 380 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 381 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 382 |
PALLOR |
1 |
0.0000 |
| 383 |
SKIN LESION |
1 |
0.0000 |
| 384 |
VISION BLURRED |
5 |
0.0000 |
| 385 |
CARDIAC ARREST |
3 |
0.0000 |
| 386 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 387 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 388 |
HAEMOPTYSIS |
1 |
0.0000 |
| 389 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 390 |
ASTHMA |
4 |
0.0000 |
| 391 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 392 |
HYPOTENSION |
7 |
0.0000 |
| 393 |
LETHARGY |
2 |
0.0000 |
| 394 |
VOMITING |
16 |
0.0000 |
| 395 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 396 |
WHEEZING |
2 |
0.0000 |
| 397 |
PREMATURE BABY |
1 |
0.0000 |
| 398 |
HEPATIC FAILURE |
1 |
0.0000 |
| 399 |
OFF LABEL USE |
29 |
0.0000 |
| 400 |
EPILEPSY |
1 |
0.0000 |
| 401 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 402 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 403 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 404 |
ASTHENIA |
12 |
0.0000 |
| 405 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 406 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 407 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 408 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 409 |
SWELLING FACE |
2 |
0.0000 |
| 410 |
CHOLELITHIASIS |
1 |
0.0000 |
| 411 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 412 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 413 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 414 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 415 |
HAEMATURIA |
1 |
0.0000 |
| 416 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 417 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 418 |
COUGH |
8 |
0.0000 |
| 419 |
HEART RATE DECREASED |
1 |
0.0000 |
| 420 |
HYPERTENSION |
6 |
0.0000 |
| 421 |
DYSPNOEA |
16 |
0.0000 |
| 422 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 423 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 424 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 425 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 426 |
MUSCLE SPASMS |
5 |
0.0000 |
| 427 |
PRODUCT DOSE OMISSION ISSUE |
8 |
0.0000 |
| 428 |
DYSURIA |
1 |
0.0000 |
| 429 |
BRONCHITIS |
2 |
0.0000 |
| 430 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 431 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 432 |
COLITIS |
1 |
0.0000 |
| 433 |
DIARRHOEA |
17 |
0.0000 |
| 434 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 435 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 436 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 437 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 438 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 439 |
DRY MOUTH |
2 |
0.0000 |
| 440 |
TREMOR |
4 |
0.0000 |
| 441 |
POLLAKIURIA |
1 |
0.0000 |
| 442 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 443 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 444 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 445 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 446 |
NAUSEA |
18 |
0.0000 |
| 447 |
TACHYCARDIA |
2 |
0.0000 |
| 448 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 449 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 450 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 451 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 452 |
BACK PAIN |
5 |
0.0000 |
| 453 |
RENAL DISORDER |
1 |
0.0000 |
| 454 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 455 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 456 |
COMA |
1 |
0.0000 |
| 457 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 458 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 459 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 460 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 461 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 462 |
THERAPY CESSATION |
1 |
0.0000 |
| 463 |
INFLAMMATION |
1 |
0.0000 |
| 464 |
SPEECH DISORDER |
1 |
0.0000 |
| 465 |
BRADYCARDIA |
1 |
0.0000 |
| 466 |
CONSTIPATION |
4 |
0.0000 |
| 467 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 468 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 469 |
INFLUENZA |
2 |
0.0000 |
| 470 |
PAIN |
11 |
0.0000 |
| 471 |
EYE PAIN |
1 |
0.0000 |
| 472 |
CONVULSION |
1 |
0.0000 |
| 473 |
DEATH |
15 |
0.0000 |
| 474 |
EYE IRRITATION |
1 |
0.0000 |
| 475 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 476 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 477 |
CATARACT |
1 |
0.0000 |
| 478 |
FATIGUE |
13 |
0.0000 |
| 479 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 480 |
VERTIGO |
1 |
0.0000 |
| 481 |
RHINORRHOEA |
1 |
0.0000 |
| 482 |
RENAL FAILURE |
2 |
0.0000 |
| 483 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 484 |
NEUTROPENIA |
2 |
0.0000 |
| 485 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 486 |
ERYTHEMA |
3 |
0.0000 |
| 487 |
WEIGHT DECREASED |
4 |
0.0000 |
| 488 |
DYSGEUSIA |
1 |
0.0000 |
| 489 |
WEIGHT INCREASED |
3 |
0.0000 |
| 490 |
CARDIAC FAILURE |
1 |
0.0000 |
| 491 |
PROSTATE CANCER |
1 |
0.0000 |
| 492 |
DIZZINESS |
6 |
0.0000 |
| 493 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 494 |
MALAISE |
5 |
0.0000 |
| 495 |
COVID-19 |
2 |
0.0000 |
| 496 |
HEADACHE |
7 |
0.0000 |
| 497 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 498 |
ADVERSE EVENT |
1 |
0.0000 |
| 499 |
DYSPHAGIA |
1 |
0.0000 |
| 500 |
CONTUSION |
1 |
0.0000 |
| 501 |
SYNCOPE |
1 |
0.0000 |
| 502 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 503 |
ILLNESS |
1 |
0.0000 |
| 504 |
ARTHRALGIA |
4 |
0.0000 |
| 505 |
OVERDOSE |
2 |
0.0000 |
| 506 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 507 |
DECREASED APPETITE |
2 |
0.0000 |
| 508 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 509 |
PRURITUS |
3 |
0.0000 |
| 510 |
HYPERHIDROSIS |
1 |
0.0000 |
| 511 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 512 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 513 |
ANXIETY |
2 |
0.0000 |
| 514 |
HYPOAESTHESIA |
1 |
0.0000 |
| 515 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 516 |
PARAESTHESIA |
1 |
0.0000 |
| 517 |
DRUG INTERACTION |
1 |
0.0000 |
| 518 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 519 |
FALL |
2 |
0.0000 |
| 520 |
URTICARIA |
1 |
0.0000 |
| 521 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 522 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 523 |
CHEST PAIN |
1 |
0.0000 |
| 524 |
RASH |
2 |
0.0000 |
| 525 |
PAIN IN EXTREMITY |
1 |
0.0000 |